RISK FACTORS FOR THE DEVELOPMENT OF EPILEPSY, TAKING INTO ACCOUNT REGIONAL CHARACTERISTICS OF THE FERGANA VALLEY
Keywords:
Fergana Valley, epilepsy, seizure, neurologyAbstract
According to the World Health Organization, the prevalence of epilepsy in developing countries is 10.3 cases per 1000 population in urban areas and 15.4 cases per 1000 population in rural areas, which is significantly higher than similar indicators in developed countries (5.8 per 1000 population). Regional patterns of epilepsy prevalence and clinical course in various regions of the Republic of Uzbekistan are still insufficiently studied.
References
[1] World Health Organization, Epilepsy: A Public Health Imperative. Geneva, Switzerland: WHO, 2019.
[2] A. Guekht, W. A. Hauser, L. Milchakova, et al., “The epidemiology of epilepsy in the Russian Federation,” Epilepsy Research, vol. 92, no. 2–3, pp. 209–218, 2016.
[3] H. Hamamy, “Consanguineous marriages: Preconception consultation in primary health care settings,” Journal of Community Genetics, vol. 3, no. 3, pp. 185–192, 2012.
[4] X. Hao, D. Goldberg, K. Kelly, L. Stephen, P. Kwan, and M. J. Brodie, “Uncontrolled epilepsy is not the same as drug-resistant epilepsy: Differences between populations with newly diagnosed epilepsy and chronic epilepsy,” Epilepsy & Behavior, vol. 29, no. 1, pp. 4–6, 2013, doi:10.1016/j.yebeh.2013.06.019.
[5] W. A. Hauser, J. F. Annegers, and L. T. Kurland, “Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984,” Epilepsia, vol. 34, no. 3, pp. 453–468, 1993.
[6] E. Hedegärd, et al., “Complications to invasive epilepsy surgery workup with subdural and depth electrodes,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 85, no. 7, pp. 716–720, 2014.
[7] A. R. Khayrullina and M. S. Sayfutdinov, “Cultural factors in epilepsy perception and treatment in Central Asia,” Epilepsy & Behavior, vol. 108, Art. no. 107094, 2020.
[8] D. Kh. Khodjaeva and R. K. Usmonov, “Epidemiological features of epilepsy in industrial regions of Uzbekistan,” Central Asian Journal of Medical Sciences, vol. 5, no. 2, pp. 112–119, 2019.
[9] R. S. Fisher, J. H. Cross, J. A. French, et al., “Operational classification of seizure types by the International League Against Epilepsy,” Epilepsia, vol. 58, no. 4, pp. 522–530, 2017.
[10] R. S. Fisher, C. Acevedo, A. Arzimanoglou, et al., “ILAE official report: A practical clinical definition of epilepsy,” Epilepsia, vol. 55, no. 4, pp. 475–482, 2014.
[11] V. A. Karlov, Epilepsy in Children and Adults: Women and Men. Moscow, Russia: Medicine Press, 2019.
[12] E. I. Gusev, A. B. Gekht, and G. S. Burd, Neurology and Neurosurgery. Moscow, Russia: GEOTAR-Media, 2021.
[13] P. Kwan and M. J. Brodie, “Early identification of refractory epilepsy,” The New England Journal of Medicine, vol. 342, no. 5, pp. 314–319, 2000.
[14] S. C. Wiebe, W. T. Blume, J. P. Girvin, and M. Eliasziw, “A randomized, controlled trial of surgery for temporal-lobe epilepsy,” The New England Journal of Medicine, vol. 345, no. 5, pp. 311–318, 2001.
[15] C. Beghi, G. Giussani, E. Nichols, et al., “Global, regional, and national burden of epilepsy, 1990–2019: A systematic analysis,” The Lancet Neurology, vol. 22, no. 7, pp. 627–639, 2023.